Nomogram for prediction of pathological complete response in human epidermal growth factor 2 (HER22) receptor positive breast cancer patients treated with neoadjuvant systemic therapy - ProQuest

Skip to main content

Document Preview

Copyright information

Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.

Access to the complete full text

This is a short preview of the document. Your library or institution may give you access to the complete full text for this document in ProQuest.

Explore ProQuest

Alternatively, you can purchase a copy of the complete full text for this document directly from ProQuest using the option below:

Nomogram for prediction of pathological complete response in human epidermal growth factor 2 (HER22) receptor positive breast cancer patients treated with neoadjuvant systemic therapy

Fujii, Takeo. The University of Texas School of Public Health ProQuest Dissertations Publishing, 2015. 1597527.